2024;9:234 Rosenstock J, Sorli CH, Trautmann ME, Morales C, Wendisch U, Dailey G, et al
GLP-1 receptor agonists are commonly associated with gastrointestinal adverse events, which may lead to dehydration in some people [112]
You can consult with licensed professionals for conditions like depression, obesity, and addiction, and receive prescriptions and personalized care plans remotely
There are also other practical reasons to prescribe these drugs in people with type 2 diabetes, because all three classes are associated with relatively low risk of hypoglycemic events, while patients treated with GLP-1RA and SGLT-2 inhibitors may also benefit from weight loss [11]
Administering the lowest effective microdose and waiting extended periods between dose increases is the standard protocol for reducing gastrointestinal distress in animal models and human trials